Government Approval of MDMA for Treating PTSD Likely
For the millions of Americans suffering from Posttraumatic Stress Disorder (PTSD), there may finally be a solution. A late-stage clinical trial of the psychedelic drug MDMA has shown great promise in treating the condition, making FDA approval likely in the next few years.
MDMA, an illegal drug commonly known as “ecstasy” or “molly” started out as a synthetic compound created in 1912. After a period of use in the treatment of mental health conditions, it escaped in the 1980s from the clinic to the dance floor and was criminalized by the FDA. But a few proponents continue to push for research, including Dr. Rick Doblin who founded the Multidisciplinary Association for Psychedelic Studies, or MAPS.
Decades later their efforts finally led to a green light from the FDA for clinical study. Since then, there have been three rigorous clinical trials, which have all shown enormous promise of the drug in combination with psychotherapy to treat PTSD.
Watch more:
About the Author
Ayahuasca Study Shows Breakthrough in Resolving Intercultural Conflict
Can plant medicines heal long-standing, sociopolitical conflicts? A new study brought together groups with deep-rooted enmity for each other in an ayahuasca ceremony—could this be the solution for a more peaceful world?
Plant medicines, including ayahuasca and psilocybin from “magic mushrooms” have become breakthrough therapeutic modalities for treating depression, anxiety, and addiction, as taboos around psychedelics fade and scientists study their effects in sanctioned clinical settings. And now a group of scientists from the US, UK, and Israel has begun to look at ayahuasca as a tool for resolving intercultural conflict. By bringing together Israelis and Palestinians for a group ceremony, the researchers looked for signs of reconciliation and intergroup contact between the subjects.
Dr. Maya Shetreat MD, is a neurologist and herbalist specializing in plant medicine and psychedelic-assisted therapy. She had this to say about the recent study…
“We should definitely be able to experience significant shifts in identity politics because we know that psychedelic medicines like ayahuasca or psilocybin have these ego-dissolving properties that change the way our brains see us, see our identity, and perceive us as being separate from one another,” Dr. Shetreat said. “So, theoretically it’s possible that any kind of identity issues, whether it be political or otherwise, could be more in a place of resolution because people can see past differences.”
Results of this recent study proved to be profound, with several participants reporting visions in which they re-lived trauma from the perspective of those from the opposite culture. And in one instance, a participant was able to embody a single experience from both perspectives.
But while these results held significant weight for those involved, how does this translate at a larger scale?
“You know we have to ask the question, is it really necessary for everyone to be in ceremony and go through a psychedelic experience in order to create change? And actually, I think there’s an argument that it doesn’t take that many people, not everybody has to be in that role and enter that liminal space. The people who are called and the people who are motivated to engage with the medicine have those revelations, integrate, take action, and actually lead other people to see those connections that other people might not be able to see,” Dr. Shetreat said.
